CCO.AX The Calmer Co (ASX) down 20.0% 16 Jan 2026 market closed: liquidity hit
CCO.AX stock plunged 20.0% to A$0.004 at market close on 16 Jan 2026, making it one of the ASX top losers today. We saw 1,622,709 shares trade on low relative volume, adding selling pressure into the close. The move follows persistent losses since the 2025 high and highlights tight liquidity and negative earnings metrics in AUD.
Market move and session summary for CCO.AX stock
The Calmer Co International Limited (CCO.AX) finished the session at A$0.004, down 20.0% from the previous close of A$0.005. Volume was 1,622,709 shares versus an average of 3,318,810, showing lower-than-normal participation. The daily range was flat at A$0.004 as bids evaporated near the close.
Fundamental snapshot and valuation for CCO.AX stock
Fundamentals show stressed profitability. EPS is -0.01 and reported PE is -0.4, reflecting losses. Price-to-sales is 1.52 and price-to-book is 5.76, signaling a rich book multiple versus weak earnings. Market cap is A$12,233,413 and shares outstanding are 3,058,353,260, which compresses per-share metrics.
Technical and liquidity signals for CCO.AX stock
Technicals show limited momentum. The 50-day average is A$0.0037 and the 200-day average is A$0.003667, both near the current price. On-chain indicators show RSI around 51.11, while on-balance volume is deeply negative. With year low A$0.002 and year high A$0.007, liquidity risk is the main driver of today’s drop.
Meyka AI rates and analyst context for CCO.AX stock
Meyka AI rates CCO.AX with a score out of 100: 68.67 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The company rating snapshot dated 15 Jan 2026 shows a D+ fundamental rating from another model, reinforcing mixed signals.
Risk drivers and sector context for CCO.AX stock
CCO.AX operates in Packaged Foods inside the Consumer Defensive sector in Australia. Sector peers trade at higher price-to-earnings and stronger margins. Key risks include negative operating margins, debt-to-equity 1.21, thin trading liquidity, and regulatory or export constraints for medicinal kava products.
Price forecast and near-term price target for CCO.AX stock
Meyka AI’s forecast model projects A$0.000955 for the next year versus the current price of A$0.004, implying an approximate -76.12% downside from today’s level. Short-term technical support is at A$0.002 and resistance is at A$0.007. Traders should treat any recovery as high risk, and institutional coverage remains scant.
Final Thoughts
CCO.AX stock closed as a top loser on 16 Jan 2026 after a sharp 20.0% intraday fall to A$0.004 on the ASX. The move reflects weak earnings, thin liquidity and high share count pressure. Financials show EPS -0.01, PE negative, P/S 1.52 and P/B 5.76, pointing to valuation stress. Our model and market indicators flag downside risk: Meyka AI’s forecast model projects A$0.000955 next year, implying about -76.12% from the current price. For risk-managed investors we set a conservative near-term price target at A$0.002 and a technical recovery case to A$0.008 if gross margins and cash flow improve. Forecasts are model-based projections and not guarantees. We use Meyka AI as an AI-powered market analysis platform to highlight liquidity and valuation as the near-term watch points.
FAQs
Why did CCO.AX stock drop 20% today?
CCO.AX stock fell due to low liquidity, negative EPS of -0.01, and heavy selling into a thin market. Volume was 1,622,709 versus a 3,318,810 average, amplifying price moves on ASX in AUD.
What is Meyka AI’s forecast for CCO.AX stock?
Meyka AI’s forecast model projects A$0.000955 for CCO.AX stock next year. That implies roughly a -76.12% downside from the current A$0.004. Forecasts are model-based projections and not guarantees.
What are key valuation metrics for CCO.AX stock?
Key metrics: EPS -0.01, PE negative at -0.4, price-to-sales 1.52 and price-to-book 5.76. Market cap is A$12,233,413 and debt-to-equity is 1.21, indicating stretched valuation versus earnings.
Should investors buy CCO.AX stock after the drop?
CCO.AX stock remains high risk. Meyka AI grades it B (HOLD) but warns of liquidity and earnings risks. Conservative investors should wait for cash-flow recovery or clearer margins before buying on ASX in AUD.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
